Skip to Content

119 Results Found

  • Article
  • Open Access
20 Citations
6,069 Views
13 Pages

Broad Protection of Pigs against Heterologous PRRSV Strains by a GP5-Mosaic DNA Vaccine Prime/GP5-Mosaic rVaccinia (VACV) Vaccine Boost

  • Junru Cui,
  • Caitlin M. O’Connell,
  • Connor Hagen,
  • Kim Sawicki and ,
  • Joan A. Smyth,
  • Paulo H. Verardi,
  • Herbert J. Van Kruiningen and
  • Antonio E. Garmendia
  • + 3 authors+ 0 author

28 February 2020

Background: Porcine reproductive and respiratory syndrome (PRRS) viruses are a major cause of disease and economic loss in pigs worldwide. High genetic diversity among PRRSV strains is problematic for successful disease control by vaccination. Mosaic...

(This article belongs to the Special Issue Vaccines against RNA Viruses)
  • Review
  • Open Access
42 Citations
12,619 Views
18 Pages

Vaccinia Virus: From Crude Smallpox Vaccines to Elaborate Viral Vector Vaccine Design

  • Onur Kaynarcalidan,
  • Sara Moreno Mascaraque and
  • Ingo Drexler

26 November 2021

Various vaccinia virus (VACV) strains were applied during the smallpox vaccination campaign to eradicate the variola virus worldwide. After the eradication of smallpox, VACV gained popularity as a viral vector thanks to increasing innovations in gene...

(This article belongs to the Special Issue Poxviruses: From Pathophysiology to Novel Therapeutic Approaches)
  • Article
  • Open Access
147 Views
13 Pages

Persistence of Vaccinia Virus-Neutralizing Antibodies and Cross-Reaction Against Monkeypox Virus Decades After Smallpox Vaccination in an Italian Population

  • Riccardo De Santis,
  • Giorgia Grilli,
  • Giovanni Faggioni,
  • Anna Anselmo and ,
  • Filippo Molinari,
  • Donatella Amatore,
  • Florigio Lista and
  • Raffaele D’Amelio
  • + 3 authors+ 0 author

10 November 2026

Background/Objectives: Routine smallpox vaccination ended after eradication, leaving uncertainty about the persistence of vaccinia virus (VACV)-neutralizing antibodies and their activity against the monkeypox virus (MPXV) responsible for the 2022 out...

(This article belongs to the Topic Advances in Vaccines and Antimicrobial Therapy—2nd Edition)
  • Article
  • Open Access
16 Citations
8,049 Views
16 Pages

Features of the Antitumor Effect of Vaccinia Virus Lister Strain

  • Evgeniy Zonov,
  • Galina Kochneva,
  • Anastasiya Yunusova,
  • Antonina Grazhdantseva and ,
  • Vladimir Richter and
  • Elena Ryabchikova
  • + 1 author+ 0 author

12 January 2016

Oncolytic abilities of vaccinia virus (VACV) served as a basis for the development of various recombinants for treating cancer; however, “natural” oncolytic properties of the virus are not examined in detail. Our study was conducted to know how the g...

(This article belongs to the Special Issue Oncolytic Viruses)
  • Article
  • Open Access
1 Citations
2,079 Views
13 Pages

eEF-2K Deficiency Boosts the Virus-Specific Effector CD8+ T Cell Responses During Viral Infection

  • Liqing Wang,
  • Benny Shone Song,
  • Rayansh Poojary,
  • Xiaofang Xiong and ,
  • Xingcong Ren,
  • Jin-Ming Yang and
  • Jianxun Song
  • + 2 authors+ 0 author

28 December 2024

In this study, we revealed a critical role of eukaryotic elongation factor-2 kinase (eEF-2K), a negative regulator of protein synthesis, in regulating T cells during vaccinia virus (VACV) infection. We found that eEF-2K-deficient (eEF-2K⁻/̿...

(This article belongs to the Special Issue Viral Mechanisms of Immune Evasion)
  • Review
  • Open Access
31 Citations
7,699 Views
9 Pages

Buffalopox Virus: An Emerging Virus in Livestock and Humans

  • Kamal H. Eltom,
  • Abdallah M. Samy,
  • Ahmed Abd El Wahed and
  • Claus-Peter Czerny

20 August 2020

Buffalopox virus (BPXV) is the cause of buffalopox, which was recognized by the FAO/WHO Joint Expert Committee on Zoonosis as an important zoonotic disease. Buffalopox was first described in India, later in other countries, and has become an emerging...

(This article belongs to the Section Animal Pathogens)
  • Article
  • Open Access
24 Citations
6,846 Views
17 Pages

Repurposing Drugs for Synergistic Combination Therapies to Counteract Monkeypox Virus Tecovirimat Resistance

  • Haydar Witwit,
  • Beatrice Cubitt,
  • Roaa Khafaji,
  • Esteban M. Castro and ,
  • Miguel Goicoechea,
  • Maria M. Lorenzo,
  • Rafael Blasco,
  • Luis Martinez-Sobrido and
  • Juan C. de la Torre
  • + 4 authors+ 0 author

13 January 2025

The ongoing monkeypox (mpox) disease outbreak has spread to multiple countries in Central Africa and evidence indicates it is driven by a more virulent clade I monkeypox virus (MPXV) strain than the clade II strain associated with the 2022 global mpo...

(This article belongs to the Special Issue Mpox (Monkeypox): From Neglected Tropical Disease to Emerging Global Pathogen)
  • Article
  • Open Access
4 Citations
3,196 Views
17 Pages

An Mpox Multi-Antigen-Tandem Bivalent mRNA Candidate Vaccine Effectively Protects Mice Against the Vaccinia Virus

  • Jun Zuo,
  • Jiayu Wu,
  • Zhen Zhang,
  • Jinrong Long and ,
  • Changxiao Yu,
  • Yuqin Liao,
  • Hongsheng Zhang and
  • Jing Yang
  • + 3 authors+ 0 author

31 March 2025

Background: Since the outbreak of mpox in 2022, the disease has spread rapidly worldwide and garnered significant public attention. Vaccination is regarded as an effective measure to prevent the spread of mpox. The success of the COVID-19 mRNA vaccin...

  • Brief Report
  • Open Access
8 Citations
3,891 Views
9 Pages

The Generation and Characterization of Monoclonal Antibodies against the MPXV A29L Protein

  • Wenlong Zhu,
  • Mengjia Zhang,
  • Mengdi Zhang,
  • Ran Jing and ,
  • Jiaru Zhou,
  • Hua Cao,
  • Changcheng Liu,
  • Hongmei Zhu,
  • Ahmed H. Ghonaim and
  • Wentao Li
  • + 6 authors+ 1 author

24 July 2024

Mpox (formerly known as monkeypox) is a zoonotic disease caused by monkeypox virus (MPXV), a DNA virus belonging to the Orthopoxvirus genus, in the Poxviridae family. The disease constitutes a moderate risk to public health at the global level. The M...

(This article belongs to the Section Viral Immunology, Vaccines, and Antivirals)
  • Review
  • Open Access
528 Views
23 Pages

20 August 2026

A lifelong career devoted to the development of specific antiviral agents eventually yielded, besides (almost) 3000 publications, about ten antiviral compounds that were approved and marketed as antiviral drugs, i.e., DHPA (Duviragel®), BVDU (Zos...

(This article belongs to the Special Issue Medicinal Chemistry and Virology Together in the Service of Human Health: In Honor of Prof. Dr. Erik De Clercq on the Occasion of His 85th Birthday)
  • Article
  • Open Access
23 Citations
5,396 Views
12 Pages

Vaccinia Virus in Blood Samples of Humans, Domestic and Wild Mammals in Brazil

  • Marina G. Peres,
  • Thais S. Bacchiega,
  • Camila M. Appolinário,
  • Acácia F. Vicente and ,
  • Mateus De Souza Ribeiro Mioni,
  • Bruna L. D. Ribeiro,
  • Clóvis R. S. Fonseca,
  • Vanessa C. Pelícia,
  • Fernando Ferreira and
  • Jane Megid
  • + 7 authors+ 2 authors

18 January 2018

Outbreaks of Vaccinia virus (VACV) affecting cattle and humans have been reported in Brazil in the last 15 years, but the origin of outbreaks remains unknown. Although VACV DNA have been already detected in mice (Mus musculus), opossums (Didelphis al...

(This article belongs to the Special Issue Smallpox and Emerging Zoonotic Orthopoxviruses: What Is Coming Next?)
  • Review
  • Open Access
49 Citations
10,982 Views
21 Pages

Vaccinia Virus Natural Infections in Brazil: The Good, the Bad, and the Ugly

  • Jaqueline Silva de Oliveira,
  • Poliana De Oliveira Figueiredo,
  • Galileu Barbosa Costa,
  • Felipe Lopes de Assis and ,
  • Betânia Paiva Drumond,
  • Flávio Guimarães Da Fonseca,
  • Maurício Lacerda Nogueira,
  • Erna Geessien Kroon and
  • Giliane De Souza Trindade
  • + 4 authors+ 0 author

15 November 2017

The orthopoxviruses (OPV) comprise several emerging viruses with great importance to human and veterinary medicine, including vaccinia virus (VACV), which causes outbreaks of bovine vaccinia (BV) in South America. Historically, VACV is the most compr...

(This article belongs to the Special Issue Smallpox and Emerging Zoonotic Orthopoxviruses: What Is Coming Next?)
  • Article
  • Open Access
15 Citations
7,637 Views
20 Pages

From Lesions to Viral Clones: Biological and Molecular Diversity amongst Autochthonous Brazilian Vaccinia Virus

  • Graziele Oliveira,
  • Felipe Assis,
  • Gabriel Almeida,
  • Jonas Albarnaz and ,
  • Maurício Lima,
  • Ana Cláudia Andrade,
  • Rafael Calixto,
  • Cairo Oliveira,
  • José Diomedes Neto and
  • Jônatas Abrahão
  • + 8 authors+ 3 authors

16 March 2015

Vaccinia virus (VACV) has had an important role for humanity because of its use during the smallpox eradication campaign. VACV is the etiologic agent of the bovine vaccinia (BV), an emerging zoonosis that has been associated with economic, social, ve...

(This article belongs to the Special Issue Poxvirus Evolution)
  • Review
  • Open Access
14 Citations
4,678 Views
15 Pages

Imaging of Virus-Infected Cells with Soft X-ray Tomography

  • Damià Garriga,
  • Francisco Javier Chichón,
  • Bárbara M. Calisto,
  • Diego S. Ferrero and ,
  • Pablo Gastaminza,
  • Eva Pereiro and
  • Ana Joaquina Pérez-Berna
  • + 2 authors+ 0 author

20 October 2021

Viruses are obligate parasites that depend on a host cell for replication and survival. Consequently, to fully understand the viral processes involved in infection and replication, it is fundamental to study them in the cellular context. Often, viral...

(This article belongs to the Section General Virology)
  • Article
  • Open Access
20 Citations
4,513 Views
21 Pages

DDX50 Is a Viral Restriction Factor That Enhances IRF3 Activation

  • Mitchell A. Pallett,
  • Yongxu Lu and
  • Geoffrey L. Smith

3 February 2022

The transcription factors IRF3 and NF-κB are crucial in innate immune signalling in response to many viral and bacterial pathogens. However, mechanisms leading to their activation remain incompletely understood. Viral RNA can be detected by RLR recep...

(This article belongs to the Section Viral Immunology, Vaccines, and Antivirals)
  • Article
  • Open Access
8 Citations
3,751 Views
21 Pages

Newly Designed Poxviral Promoters to Improve Immunogenicity and Efficacy of MVA-NP Candidate Vaccines against Lethal Influenza Virus Infection in Mice

  • Martin C. Langenmayer,
  • Anna-Theresa Luelf-Averhoff,
  • Lisa Marr,
  • Sylvia Jany and ,
  • Astrid Freudenstein,
  • Silvia Adam-Neumair,
  • Alina Tscherne,
  • Robert Fux,
  • Juan J. Rojas and
  • Asisa Volz
  • + 7 authors+ 2 authors

Influenza, a respiratory disease mainly caused by influenza A and B, viruses of the Orthomyxoviridae, is still a burden on our society’s health and economic system. Influenza A viruses (IAV) circulate in mammalian and avian populations, causing...

(This article belongs to the Special Issue Animal Models for Human Viruses)
  • Article
  • Open Access
7 Citations
3,157 Views
18 Pages

Enhanced Anti-Herpetic Activity of Valacyclovir Loaded in Sulfobutyl-ether-β-cyclodextrin-decorated Chitosan Nanodroplets

  • Monica Argenziano,
  • Irene Arduino,
  • Massimo Rittà,
  • Chiara Molinar and ,
  • Elisa Feyles,
  • David Lembo,
  • Roberta Cavalli and
  • Manuela Donalisio
  • + 3 authors+ 0 author

Valacyclovir (VACV) was developed as a prodrug of the most common anti-herpetic drug Acyclovir (ACV), aiming to enhance its bioavailability. Nevertheless, prolonged VACV oral treatment may lead to the development of important side effects. Nanotechno...

(This article belongs to the Special Issue Innovative Antiviral Approaches and New Molecular Targets against Viral Infections)
  • Article
  • Open Access
6 Citations
4,268 Views
12 Pages

18 July 2022

The vaccinia virus (VACV) was previously used as a vaccine for smallpox eradication. Nowadays, recombinant VACVs are developed as vaccine platforms for infectious disease prevention and cancer treatment. The conventional method for genome editing of...

(This article belongs to the Special Issue Poxvirus)
  • Article
  • Open Access
16 Citations
5,117 Views
22 Pages

In Silico Analysis and Functional Characterization of Antimicrobial and Insecticidal Vicilin from Moth Bean (Vigna aconitifolia (Jacq.) Marechal) Seeds

  • Muhammad Ateeq,
  • Muhammad Muzammal Adeel,
  • Ayesha Kanwal,
  • Muhammad Tahir ul Qamar and ,
  • Ahsan Saeed,
  • Binish Khaliq,
  • Qamar Saeed,
  • Muhammad Nauman Atiq,
  • Muhammad Bilal and
  • Ahmed Akrem
  • + 7 authors+ 2 authors

Vicilin has nutraceutical potential and different noteworthy medicative health-promoting biotic diversions, and it is remarkable against pathogenic microorganisms and insects. In this study, Vigna aconitifolia vicilin (VacV) has been identified and c...

(This article belongs to the Special Issue Bioactive Molecules for Biodegradation and Antimicrobials)
  • Article
  • Open Access
4 Citations
5,558 Views
10 Pages

A Model to Detect Autochthonous Group 1 and 2 Brazilian Vaccinia virus Coinfections: Development of a qPCR Tool for Diagnosis and Pathogenesis Studies

  • Rafael Calixto,
  • Graziele Oliveira,
  • Maurício Lima,
  • Ana Cláudia Andrade and ,
  • Giliane De Souza Trindade,
  • Danilo Bretas De Oliveira and
  • Erna Geessien Kroon
  • + 2 authors+ 0 author

30 December 2017

Vaccinia virus (VACV) is the etiological agent of bovine vaccinia (BV), an emerging zoonosis that has been associated with economic losses and social effects. Despite increasing reports of BV outbreaks in Brazil, little is known about the biological...

(This article belongs to the Special Issue Smallpox and Emerging Zoonotic Orthopoxviruses: What Is Coming Next?)
  • Review
  • Open Access
5 Citations
17,049 Views
18 Pages

Use of Reporter Genes in the Generation of Vaccinia Virus-Derived Vectors

  • Sally Al Ali,
  • Sara Baldanta,
  • Mercedes Fernández-Escobar and
  • Susana Guerra

21 May 2016

Vaccinia virus (VACV) is one of the most extensively-studied viruses of the Poxviridae family. It is easy to genetically modify, so it has become a key tool for many applications. In this context, reporter genes facilitate the study of the role of fo...

(This article belongs to the Special Issue Replication-Competent Reporter-Expressing Viruses)
  • Article
  • Open Access
11 Citations
4,653 Views
9 Pages

Vaccinia virus in Feces and Urine of Wild Rodents from São Paulo State, Brazil

  • Marina G. Peres,
  • Thais S. Bacchiega,
  • Camila M. Appolinário,
  • Acácia F. Vicente and ,
  • Mateus S. R. Mioni,
  • Bruna L. D. Ribeiro,
  • Clóvis R. S. Fonseca,
  • Vanessa C. Pelícia,
  • Fernando Ferreira and
  • Jane Megid
  • + 6 authors+ 1 author

23 January 2018

The origin of Vaccinia virus (VACV) outbreaks in Brazil remains unknown, but since the isolation of VACV in Mus musculus mice during a zoonotic outbreak affecting cattle and milkers, peridomestic rodents have been suggested to be a link between cows...

(This article belongs to the Special Issue Smallpox and Emerging Zoonotic Orthopoxviruses: What Is Coming Next?)
  • Article
  • Open Access
9 Citations
1,961 Views
21 Pages

Isolation and Characterization of E8 Monoclonal Antibodies from Donors Vaccinated with Recombinant Vaccinia Vaccine with Efficient Neutralization of Authentic Monkeypox Virus

  • Yutao Shi,
  • Shuhui Wang,
  • Yanling Hao,
  • Xiuli Shen and ,
  • Jun Zhang,
  • Shuo Wang,
  • Junjie Zhang,
  • Yuyu Fu,
  • Ran Chen and
  • Ying Liu
  • + 8 authors+ 3 authors

27 April 2025

Background/Objectives: Monkeypox, twice declared a public health emergency of international concern by the WHO, currently lacks approved targeted therapeutics. This study focused on the development of monkeypox virus (MPXV) E8-specific human monoclon...

  • Article
  • Open Access
13 Citations
10,751 Views
17 Pages

Incongruencies in Vaccinia Virus Phylogenetic Trees

  • Chad Smithson,
  • Samantha Kampman,
  • Benjamin M. Hetman and
  • Chris Upton

14 October 2014

Over the years, as more complete poxvirus genomes have been sequenced, phylogenetic studies of these viruses have become more prevalent. In general, the results show similar relationships between the poxvirus species; however, some inconsistencies a...

(This article belongs to the Special Issue Genomes and Evolution: Computational Approaches)
  • Article
  • Open Access
6 Citations
4,027 Views
16 Pages

Genomic Characterization of the Historical Smallpox Vaccine Strain Wyeth Isolated from a 1971 Seed Vial

  • Nádia Vaez G. Cruz,
  • Matheus Nobrega Luques,
  • Terezinha Marta Pereira P. Castiñeiras,
  • Orlando Costa Ferreira Jr and ,
  • Regina Helena S. Peralta,
  • Luciana J. da Costa and
  • Clarissa R. Damaso
  • + 2 authors+ 0 author

28 December 2022

The Wyeth strain of vaccinia virus (VACV) produced by Wyeth Pharmaceuticals was supposedly used to manufacture the old freeze-dried American smallpox vaccine, Dryvax, until its discontinuation in 2008. Although the genomic sequences of numerous Dryva...

(This article belongs to the Special Issue Diagnostics, Antiviral Therapy and Vaccination against Orthopoxvirus Infections)
  • Article
  • Open Access
10 Citations
3,637 Views
12 Pages

Adaptive Immune Response to Vaccinia Virus LIVP Infection of BALB/c Mice and Protection against Lethal Reinfection with Cowpox Virus

  • Sergei N. Shchelkunov,
  • Alexander A. Sergeev,
  • Stanislav N. Yakubitskiy,
  • Ksenia A. Titova and ,
  • Stepan A. Pyankov,
  • Irina V. Kolosova,
  • Ekaterina V. Starostina,
  • Mariya B. Borgoyakova,
  • Alexey M. Zadorozhny and
  • Larisa I. Karpenko
  • + 7 authors+ 2 authors

17 August 2021

Mass vaccination has played a critical role in the global eradication of smallpox. Various vaccinia virus (VACV) strains, whose origin has not been clearly documented in most cases, have been used as live vaccines in different countries. These VACV s...

(This article belongs to the Section Animal Viruses)
  • Article
  • Open Access
9 Citations
5,426 Views
13 Pages

The Host Factor Early Growth Response Gene (EGR-1) Regulates Vaccinia virus Infectivity during Infection of Starved Mouse Cells

  • Leonardo C. De Oliveira,
  • Bruno S. A. F. Brasil,
  • Bethany Unger,
  • Giliane S. Trindade and ,
  • Jonatas S. Abrahão,
  • Erna G. Kroon,
  • Paula Traktman and
  • Cláudio A. Bonjardim
  • + 3 authors+ 0 author

21 March 2018

Evolution has equipped poxvirus genomes with the coding capacity for several virus-host interaction products which interfere with host cell gene expression and protein function, creating an adequate intracellular environment for a productive infectio...

(This article belongs to the Special Issue Smallpox and Emerging Zoonotic Orthopoxviruses: What Is Coming Next?)
  • Communication
  • Open Access
2 Citations
1,675 Views
8 Pages

Vaccinia and Monkeypox Virus-Neutralizing Antibodies in People Living with HIV: A Serological Study in a Orthopoxvirus-Endemic, Low-Income Region in Brazil

  • Thyago José Silva,
  • Ana Gabriella Stoffella-Dutra,
  • Victor Lacerda Gripp,
  • Pollyana R. C. Gorgens and ,
  • Iago José da Silva Domingos,
  • Pedro Henrique Bastos e Silva,
  • Bruna Caroline Chaves-Garcia,
  • Erna Geessien Kroon,
  • Etel Rocha-Vieira and
  • Danilo Bretas de Oliveira
  • + 6 authors+ 1 author

Co-infections of Orthopoxviruses (OPVs), such as vaccinia virus (VACV) and monkeypox virus (MPXV), and the human immunodeficiency virus (HIV) can be associated with severe outcomes. Serro’s dairy region, located in Minas Gerais, southeastern Br...

(This article belongs to the Section Emerging Pathogens)
  • Article
  • Open Access
28 Citations
9,490 Views
14 Pages

Effect of ASP2151, a Herpesvirus Helicase-Primase Inhibitor, in a Guinea Pig Model of Genital Herpes

  • Kiyomitsu Katsumata,
  • Koji Chono,
  • Kenji Sudo,
  • Yasuaki Shimizu and ,
  • Toru Kontani and
  • Hiroshi Suzuki
  • + 1 author+ 0 author

25 August 2011

ASP2151 is a herpesvirus helicase-primase inhibitor with antiviral activity against varicella zoster virus and herpes simplex virus types 1 (HSV-1) and 2 (HSV-2). Here, we examined the potency and efficacy of ASP2151 against HSV in vitro and in vivo....

(This article belongs to the Special Issue Antivirals)
  • Article
  • Open Access
9 Citations
3,352 Views
13 Pages

Enhancing the Immunogenicity of Vaccinia Virus

  • Sergei N. Shchelkunov,
  • Stanislav N. Yakubitskiy,
  • Alexander A. Sergeev,
  • Ekaterina V. Starostina and ,
  • Ksenia A. Titova,
  • Stepan A. Pyankov,
  • Galina A. Shchelkunova,
  • Mariya B. Borgoyakova,
  • Alexey M. Zadorozhny and
  • Larisa I. Karpenko
  • + 7 authors+ 2 authors

30 June 2022

The conventional live smallpox vaccine based on the vaccinia virus (VACV) cannot be widely used today because it is highly reactogenic. Therefore, there is a demand for designing VACV variants possessing enhanced immunogenicity, making it possible to...

(This article belongs to the Special Issue Poxvirus)
  • Article
  • Open Access
14 Citations
5,860 Views
21 Pages

Vaccinia Virus Arrests and Shifts the Cell Cycle

  • Caroline K. Martin,
  • Jerzy Samolej,
  • Annabel T. Olson,
  • Cosetta Bertoli and ,
  • Matthew S. Wiebe,
  • Robertus A. M. de Bruin and
  • Jason Mercer
  • + 2 authors+ 0 author

19 February 2022

Modulation of the host cell cycle is a common strategy used by viruses to create a pro-replicative environment. To facilitate viral genome replication, vaccinia virus (VACV) has been reported to alter cell cycle regulation and trigger the host cell D...

(This article belongs to the Special Issue Poxvirus)
  • Article
  • Open Access
770 Views
18 Pages

Age-Related Immune Response to Previous Smallpox Vaccination in Albanian Subjects and Cross-Reactivity Between Vaccinia Virus and Monkeypox Virus Antigens

  • Adriana Manuka,
  • Irsida Mehmeti,
  • Antonia Radaelli,
  • Hamide Shllaku-Sefa and ,
  • Ndok Marku,
  • Eduart Hashorva,
  • Carlo Zanotto and
  • Carlo De Giuli Morghen
  • + 3 authors+ 0 author

10 October 2026

Background/Objectives: Recent outbreaks of the mpox virus (MPVX) have highlighted the threat posed by the Orthopoxvirus (OPXV) genus, which includes variola, the causative agent of smallpox. Since routine Vaccinia virus (VACV) vaccination campaigns t...

(This article belongs to the Section Vaccines, Clinical Advancement, and Associated Immunology)
  • Review
  • Open Access
59 Citations
15,705 Views
22 Pages

From Crescent to Mature Virion: Vaccinia Virus Assembly and Maturation

  • Liang Liu,
  • Tamara Cooper,
  • Paul M. Howley and
  • John D. Hayball

7 October 2014

Vaccinia virus (VACV) has achieved unprecedented success as a live viral vaccine for smallpox which mitigated eradication of the disease. Vaccinia virus has a complex virion morphology and recent advances have been made to answer some of the key out...

(This article belongs to the Special Issue Virus Maturation)
  • Article
  • Open Access
18 Citations
7,527 Views
21 Pages

Serro 2 Virus Highlights the Fundamental Genomic and Biological Features of a Natural Vaccinia Virus Infecting Humans

  • Giliane De Souza Trindade,
  • Ginny L. Emerson,
  • Scott Sammons,
  • Michael Frace and ,
  • Dhwani Govil,
  • Bruno Eduardo Fernandes Mota,
  • Jônatas Santos Abrahão,
  • Felipe Lopes De Assis,
  • Melissa Olsen-Rasmussen and
  • Inger K. Damon
  • + 10 authors+ 5 authors

10 December 2016

Vaccinia virus (VACV) has been implicated in infections of dairy cattle and humans, and outbreaks have substantially impacted local economies and public health in Brazil. During a 2005 outbreak, a VACV strain designated Serro 2 virus (S2V) was collec...

(This article belongs to the Section Animal Viruses)
  • Article
  • Open Access
31 Citations
7,986 Views
20 Pages

Identification of Vaccinia Virus Inhibitors and Cellular Functions Necessary for Efficient Viral Replication by Screening Bioactives and FDA-Approved Drugs

  • Chen Peng,
  • Yanan Zhou,
  • Shuai Cao,
  • Anil Pant and ,
  • Marlene L. Campos Guerrero,
  • Peter McDonald,
  • Anuradha Roy and
  • Zhilong Yang
  • + 3 authors+ 0 author

Four decades after the eradication of smallpox, poxviruses continue to threaten the health of humans and other animals. Vaccinia virus (VACV) was used as the vaccine that successfully eradicated smallpox and is a prototypic member of the poxvirus fam...

(This article belongs to the Section Vaccination Against Cancer and Chronic Diseases)
  • Communication
  • Open Access
4 Citations
3,104 Views
10 Pages

Orthopoxvirus Circulation in an Endemic Area in Brazil: Investigation of Infections in Small Mammals during an Absence of Outbreaks

  • Iago J. S. Domingos,
  • Kamila L. S. Rocha,
  • Jessica M. Graciano,
  • Lara R. Almeida and ,
  • Jeffrey B. Doty,
  • Adriano P. Paglia,
  • Danilo B. Oliveira,
  • Yoshinori J. Nakazawa and
  • Giliane de S. Trindade
  • + 4 authors+ 0 author

25 March 2023

Vaccinia virus (VACV) is the causative agent of an emerging viral zoonosis called bovine vaccinia (BV). Several studies have documented characteristics of VACV infections in Brazil; however, the manner in which this virus is maintained in wildlife re...

(This article belongs to the Collection Poxviruses)
  • Article
  • Open Access
2 Citations
1,750 Views
20 Pages

Molecular Determinants of Species-Specific Interactions Between Protein Kinase R and Poxvirus K3 Orthologs

  • Chorong Park,
  • Greg Brennan,
  • Chen Peng,
  • Chi Zhang and ,
  • Jingxin Cao,
  • Loubna Tazi and
  • Stefan Rothenburg
  • + 2 authors+ 0 author

26 November 2025

Protein kinase R (PKR) is an antiviral protein that is involved in molecular “arms races” with viral antagonists. As a result, some PKR inhibitors, including the vaccinia virus (VACV) protein K3 and its orthologs from other poxviruses onl...

(This article belongs to the Special Issue Viral Strategies and Cellular Countermeasures That Regulate mRNA Access to the Translation Apparatus: 2nd Edition)
  • Review
  • Open Access
31 Citations
14,084 Views
23 Pages

Vaccinia Virus as a Master of Host Shutoff Induction: Targeting Processes of the Central Dogma and Beyond

  • Pragyesh Dhungel,
  • Fernando M. Cantu,
  • Joshua A. Molina and
  • Zhilong Yang

The synthesis of host cell proteins is adversely inhibited in many virus infections, whereas viral proteins are efficiently synthesized. This phenomenon leads to the accumulation of viral proteins concurrently with a profound decline in global host p...

(This article belongs to the Special Issue Poxviruses: Novel Concepts and Emerging Trends)
  • Article
  • Open Access
4 Citations
3,627 Views
20 Pages

Vaccinia Virus Expressing Interferon Regulatory Factor 3 Induces Higher Protective Immune Responses against Lethal Poxvirus Challenge in Atopic Organism

  • Hana Pilna,
  • Vera Hajkova,
  • Jarmila Knitlova,
  • Jana Liskova and ,
  • Jana Elsterova and
  • Zora Melkova
  • + 1 author+ 0 author

3 October 2021

Vaccinia virus (VACV) is an enveloped DNA virus from the Orthopoxvirus family, various strains of which were used in the successful eradication campaign against smallpox. Both original and newer VACV-based replicating vaccines reveal a risk of seriou...

(This article belongs to the Special Issue Virology in the Czech Republic – from a Great Legacy to Optimistic Future)
  • Article
  • Open Access
128 Views
29 Pages

Dendritic Cells Undergo Cytoskeletal, Adhesive, and Inflammatory Remodeling During Productive Infection with Vaccinia Virus Western Reserve

  • Zuzanna Biernacka,
  • Marta Markowska,
  • Mateusz Wróblewski,
  • Adrianna Niedzielska and ,
  • Katarzyna Zawadzka,
  • Michał Koper,
  • Karolina Gregorczyk-Zboroch,
  • Iwona Lasocka,
  • Małgorzata Gieryńska and
  • Lidia Szulc-Dąbrowska
  • + 9 authors+ 4 authors

12 November 2026

Dendritic cells (DCs) are professional antigen-presenting cells (APCs) that regulate key aspects of innate and adaptive immunity. Their functions rely on dynamic cytoskeletal remodeling and specialized adhesive structures, including podosomes and foc...

(This article belongs to the Special Issue Advances on Viral Immunology and Pathogenesis of Viral Infections)
  • Review
  • Open Access
44 Citations
8,064 Views
33 Pages

Modulating Vaccinia Virus Immunomodulators to Improve Immunological Memory

  • Jonas D. Albarnaz,
  • Alice A. Torres and
  • Geoffrey L. Smith

28 February 2018

The increasing frequency of monkeypox virus infections, new outbreaks of other zoonotic orthopoxviruses and concern about the re-emergence of smallpox have prompted research into developing antiviral drugs and better vaccines against these viruses. T...

(This article belongs to the Special Issue Smallpox and Emerging Zoonotic Orthopoxviruses: What Is Coming Next?)
  • Article
  • Open Access
11 Citations
5,797 Views
14 Pages

Engineered vaccinia virus (VACV) strains are used extensively as vectors for the development of novel cancer vaccines and cancer therapeutics. In this study, we describe for the first time a high-throughput approach for both fluorescent rVACV generat...

(This article belongs to the Special Issue Oncolytic Viruses as a Novel Form of Immunotherapy for Cancer III)
  • Review
  • Open Access
5 Citations
3,882 Views
13 Pages

Antagonism of Protein Kinase R by Large DNA Viruses

  • Annabel T. Olson,
  • Stephanie J. Child and
  • Adam P. Geballe

Decades of research on vaccinia virus (VACV) have provided a wealth of insights and tools that have proven to be invaluable in a broad range of studies of molecular virology and pathogenesis. Among the challenges that viruses face are intrinsic host...

(This article belongs to the Special Issue Poxvirus-Driven Insights into Virus and Host Biology)
  • Article
  • Open Access
42 Citations
6,503 Views
20 Pages

Imprinted Contact Lenses for Ocular Administration of Antiviral Drugs

  • Angela Varela-Garcia,
  • José Luis Gomez-Amoza,
  • Angel Concheiro and
  • Carmen Alvarez-Lorenzo

4 September 2020

A variety of ocular diseases are caused by viruses, and most treatments rely on the use of systemic formulations and eye drops. The efficient ocular barriers that oppose antiviral drug penetration have prompted the development of improved topical del...

(This article belongs to the Special Issue State-of-the-Art Polymer Science and Technology in Spain (2020,2021))
  • Article
  • Open Access
6 Citations
4,662 Views
20 Pages

Species-Specific Conservation of Linear Antigenic Sites on Vaccinia Virus A27 Protein Homologs of Orthopoxviruses

  • Henrike P. Ahsendorf,
  • Li L. Gan,
  • Kamal H. Eltom,
  • Ahmed Abd El Wahed and ,
  • Sven-Kevin Hotop,
  • Rachel L. Roper,
  • Ulrike Beutling,
  • Mark Broenstrup,
  • Christiane Stahl-Hennig and
  • Claus-Peter Czerny
  • + 6 authors+ 1 author

29 May 2019

The vaccinia virus (VACV) A27 protein and its homologs, which are found in a large number of members of the genus Orthopoxvirus (OPXV), are targets of viral neutralization by host antibodies. We have mapped six binding sites (epitopes #1A: aa 32–39,...

(This article belongs to the Section Animal Viruses)
  • Article
  • Open Access
16 Citations
3,887 Views
13 Pages

New p35 (H3L) Epitope Involved in Vaccinia Virus Neutralization and Its Deimmunization

  • Yana Khlusevich,
  • Andrey Matveev,
  • Lyudmila Emelyanova,
  • Elena Goncharova and ,
  • Natalia Golosova,
  • Ivan Pereverzev and
  • Nina Tikunova
  • + 2 authors+ 0 author

5 June 2022

Vaccinia virus (VACV) is a promising oncolytic agent because it exhibits many characteristic features of an oncolytic virus. However, its effectiveness is limited by the strong antiviral immune response induced by this virus. One possible approach to...

(This article belongs to the Special Issue Poxvirus)
  • Review
  • Open Access
21 Citations
9,259 Views
13 Pages

Bovine Vaccinia: Insights into the Disease in Cattle

  • Ana Carolina Diniz Matos,
  • Izabelle Silva Rehfeld,
  • Maria Isabel Maldonado Coelho Guedes and
  • Zélia Inês Portela Lobato

9 March 2018

Bovine vaccinia (BV), caused by Vaccinia virus (VACV), is a zoonosis characterized by exanthematous lesions in the teats of dairy cows and the hands of milkers and is an important public health issue. Severe VACV-induced lesions in the teats and udde...

(This article belongs to the Special Issue Smallpox and Emerging Zoonotic Orthopoxviruses: What Is Coming Next?)
  • Article
  • Open Access
3 Citations
3,394 Views
11 Pages

Acid Stripping after Infection Improves the Detection of Viral HLA Class I Natural Ligands Identified by Mass Spectrometry

  • Elena Lorente,
  • Miguel Marcilla,
  • Patricia G. de la Sota,
  • Adriana Quijada-Freire and ,
  • Carmen Mir and
  • Daniel López
  • + 1 author+ 0 author

29 September 2021

Identification of a natural human leukocyte antigen (HLA) ligandome is a key element to understand the cellular immune response. Advanced high throughput mass spectrometry analyses identify a relevant, but not complete, fraction of the many tens of t...

(This article belongs to the Section Molecular Immunology)
  • Article
  • Open Access
13 Citations
4,939 Views
13 Pages

Single Dose of Recombinant Chimeric Horsepox Virus (TNX-801) Vaccination Protects Macaques from Lethal Monkeypox Challenge

  • Ryan S. Noyce,
  • Landon W. Westfall,
  • Siobhan Fogarty,
  • Karen Gilbert and ,
  • Onesmo Mpanju,
  • Helen Stillwell,
  • José Esparza,
  • Bruce Daugherty,
  • Fusataka Koide and
  • Seth Lederman
  • + 6 authors+ 1 author

26 January 2023

The ongoing global Monkeypox outbreak that started in the spring of 2022 has reinforced the importance of protecting the population using live virus vaccines based on the vaccinia virus (VACV). Smallpox also remains a biothreat and although some U.S....

(This article belongs to the Special Issue The 4th Symposium of the Canadian Society for Virology 2022)
  • Article
  • Open Access
12 Citations
10,235 Views
26 Pages

Protective Effect of Surfactant Protein D in Pulmonary Vaccinia Virus Infection: Implication of A27 Viral Protein

  • Julien Perino,
  • Nicole M. Thielens,
  • Erika Crouch,
  • Danièle Spehner and ,
  • Jean-Marc Crance and
  • Anne-Laure Favier
  • + 1 author+ 0 author

21 March 2013

Vaccinia virus (VACV) was used as a surrogate of variola virus (VARV) (genus Orthopoxvirus), the causative agent of smallpox, to study Orthopoxvirus infection. VARV is principally transmitted between humans by aerosol droplets. Once inhaled, VARV fir...

(This article belongs to the Section Animal Viruses)

of 3